会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明专利
    • Iron supplement and utilization of the same
    • 铁的补充和利用
    • JP2005225874A
    • 2005-08-25
    • JP2005006829
    • 2005-01-13
    • Gekkeikan Sake Co Ltd月桂冠株式会社
    • SUZUKI SACHIKOFUKUDA KATSUHARUIRIE MOTOKOHATA YOJIKAWATO SHOJIABE YASUHISA
    • A23L2/52A23L1/304A61K31/395A61K33/26A61K36/06A61P7/06
    • PROBLEM TO BE SOLVED: To obtain an iron supplement exhibiting a high iron absorption rate into a living body, a preventing or treating agent of iron-deficiency anemia, a food additive and a food composition. SOLUTION: This iron supplement, the preventing or treating agent of the iron deficiency anemia, the food additive or the food composition contains siderophore and ferric ion preferably as a chelate complex form. The chelate complex of the siderophore with ferric ion has a high absorption rate into the living body, increases hemoglobin concentration in blood, iron concentration in serum and stored iron concentration in liver by being absorbed in the living body and does not give any adverse effect on living body functions. COPYRIGHT: (C)2005,JPO&NCIPI
    • 要解决的问题:获得在生物体中表现出高的铁吸收率的铁补充剂,缺铁性贫血的预防或治疗剂,食品添加剂和食物组合物。 解决方案:该铁补充剂,缺铁性贫血的预防或治疗剂,食品添加剂或食物组合物优选含有铁螯合物和铁离子作为螯合络合物形式。 铁载体与铁离子的螯合物对人体的吸收率高,血液中血红蛋白浓度升高,血液中铁浓度升高,肝脏中铁浓度被吸收在生物体内,不会对生物体产生不利影响 活体功能。 版权所有(C)2005,JPO&NCIPI
    • 7. 发明专利
    • Method for producing phenylacetaldehyde
    • 生产苯乙酮的方法
    • JP2003310289A
    • 2003-11-05
    • JP2002118169
    • 2002-04-19
    • Gekkeikan Sake Co Ltd月桂冠株式会社
    • OBATA HIROSHIHATA YOJIKAWATO SHOJIABE YASUHISA
    • C12P7/24
    • PROBLEM TO BE SOLVED: To provide a new method for producing phenylacetaldehyde, based on surprising discovery that a side chain of an aromatic ring of phenylalanine is decarboxylated and deaminated by conducting reaction in which the phenylalanine is used as a substrate and a tyrosinase is added thereto, therefore capable of efficiently producing the phenylacetaldehyde by conducting decarboxylation/deamination reaction of the phenylalanine in the presence of the tyrosinase, and further capable of easily producing the phenylacetaldehyde with high safety at a low cost by adopting at first a biochemical process which is different from synthetic processes conventionally conducted.
      SOLUTION: This method for producing the phenylacetoaldehyde comprises reacting the tyrosinase (for example, monophenol, dihydroxyphenyl alanine- oxygen oxidoreductase, EC1.14.18.1; and catechol oxidase, EC1.10.3.1) with the phenylalanine.
      COPYRIGHT: (C)2004,JPO
    • 要解决的问题:提供一种新的苯乙醛生产方法,基于惊人的发现,苯丙氨酸芳环的侧链脱羧并通过进行苯丙氨酸用作底物的反应脱氨,酪氨酸酶 因此能够通过在酪氨酸酶的存在下进行苯丙氨酸的脱羧/脱氨反应而有效地制备苯乙醛,并且通过首先采用生物化学方法进一步能够以低成本容易地以高安全性生产苯乙醛 与常规进行的合成方法不同。 解决方案:该制备苯乙胺的方法包括将酪氨酸酶(例如单酚,二羟苯基丙氨酸 - 氧氧化还原酶,EC1.14.18.1;和邻苯二酚氧化酶,EC1.10.3.1)与苯丙氨酸反应。 版权所有(C)2004,JPO
    • 10. 发明专利
    • Autonomic nerve regulator
    • 自动神经调节器
    • JP2011126833A
    • 2011-06-30
    • JP2009288305
    • 2009-12-18
    • Gekkeikan Sake Co LtdOsaka Bioscience Institute月桂冠株式会社財団法人大阪バイオサイエンス研究所
    • TSUTSUMI HIROKOSUZUKI SACHIKOHATA YOJIABE YASUHISAURADE YOSHIHIROHUANG ZHI-LIMATSUMOTO NAOMIMASAKI MIKA
    • A61K36/00A23L1/30A23L2/38A23L2/52A61K36/899A61P25/02
    • PROBLEM TO BE SOLVED: To provide an autonomic nerve regulator utilizing an intermediate, a final product and their processed materials yielded at the production processes of sake, such as a sake lees-processed material.
      SOLUTION: This autonomic nerve regulator includes the sake lees-processed material yielded by the liquefied preparation of sake. The sake lees-processed material is obtained by performing at least one treatment selected from the group consisting of the following (1) to (3) on the sake lees. In (1) protease treatment, (2) cellulase treatment, and (3) lactobacillus fermentation treatment, and it is preferable to use a neutral protease or an acidic protease in the protease treatment, to use endoglucanase or cellobiohydrolase in the cellulase treatment, and to use Lactobacillus brevis, Lactobacillus bulgaricus, etc., in the lactobacillus fermentation treatment.
      COPYRIGHT: (C)2011,JPO&INPIT
    • 要解决的问题:提供利用中间体,最终产品及其在清酒生产过程中产生的最终产品及其加工材料的自主神经调节剂,例如酒精加工材料。

      解决方案:这种自主神经调节剂包括由液化液制成的清酒产品。 通过在清酒桶中进行选自由以下(1)至(3)组成的组中的至少一种处理,从而获得食品加工材料。 在(1)蛋白酶处理,(2)纤维素酶处理和(3)乳酸杆菌发酵处理中,优选在蛋白酶处理中使用中性蛋白酶或酸性蛋白酶,在纤维素酶处理中使用内切葡聚糖酶或纤维二糖水解酶, 在乳杆菌发酵处理中使用短乳杆菌(Lactobacillus brevis),保加利亚乳杆菌(Lactobacillus bulgaricus)等。 版权所有(C)2011,JPO&INPIT